NCCN Guidelines for Cervical Cancer now include Puma's neratinib monotherapy for 2nd line or later use in patients with ...

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.

The difference between hereditary (germline) and acquired (somatic) gene mutations in cancer can lead to much confusion. This is especially true if you’re hearing about genetic testing for a genetic ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Aging brings two opposing trends in cancer risk: first, the risk climbs in our 60s and 70s, as decades of genetic mutations ...

Large-scale protein and gene profiling have massively expanded the landscape of cancer-associated proteins and gene mutations ...

These surgeries significantly reduced risk of death or cancer recurrence. Women with BRCA1 mutations benefitted most FRIDAY, ...

Younger patients with breast cancer and the BRCA gene showed improved survival after undergoing risk-reducing mastectomy ...

New research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from returning ...

A once-a-day tablet for advanced breast cancer will be rolled out on the NHS. More than 1,000 women will be eligible for the ...